SCHEMBL5198538

SCHEMBL5198538

CCOCCC1OC(CC(C)C(N)=O)C(O)C(O)C1O

nearest known ligand 0.35

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
SELP P16109 2/20 0.35
IGF2R P11717 1/20 0.33
IDUA P35475 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5196915 0.86 SELP (0.38) SELP
SCHEMBL5197120 0.84 IDUA (0.36) IGF2RIDUA
SCHEMBL5198747 0.81 IDUA (0.36) IGF2RIDUA
SCHEMBL5199500 0.78 IDUA (0.34) IDUA
SCHEMBL4864020 0.77 IDUA (0.33) SELPIGF2RIDUA
SCHEMBL5197001 0.77 PYGB (0.41)
SCHEMBL5197875 0.77 IDUA (0.33) IDUA
SCHEMBL5198526 0.72
SCHEMBL5199046 0.71 LGALS3 (0.38)
SCHEMBL5198276 0.70 LGALS3 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1814893-A2 NOVEL LINCOMYCIN DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY Vicuron Pharmaceuticals, Inc. (US) 2007-08-08 EP disclosed
WO-2006055070-A2 NOVEL LINCOMYCIN DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY VICURON PHARMACEUTICALS INC. (US) 2006-05-26 WO disclosed
EP-1644393-A2 NOVEL LINCOMYCIN DERIVATIVES POSSESSING ANTIMICROBIAL ACTIVITY Vicuron Pharmaceuticals, Inc. (US) 2006-04-12 EP disclosed
WO-2005012320-A2 NOVEL LINCOMYCIN DERIVATIVES POSSESSING ANTIMICROBIAL ACTIVITY VICURON PHARMACEUTICALS, INC. (US) 2005-02-10 WO disclosed